MAG

As the philosophy of precision pet care continues to deepen, pet health management has advanced from basic nutrition to an era of precision and specialized care. Joint health, the cornerstone of canine and feline vitality, directly impacts quality of life and longevity.

MAG Fast Joint Health 1+1 is specifically formulated to address joint-related concerns in dogs and cats, including degenerative joint disease, athletic injuries, and inflammatory conditions. Powered by UC-II® Undenatured Type II Collagen core technology, it features an AM/PM Dosing System: Daytime Nutritional Defense to support active mobility, and Nighttime Deep Repair to aid tissue recovery. This scientifically designed solution delivers professional, efficient, and safe comprehensive joint care.

Core Ingredient: UC-II® Undenatured Type II Collagen UC-II® Undenatured Type II Collagen is the core active protein of joint cartilage, produced via a Patented Low-Temperature Extraction Process that fully preserves its natural triple-helix structure and consistent biological activity. Unlike conventional denatured collagen, it requires no complex decomposition for absorption by the body, and a daily micro-dose of 40mg delivers significant efficacy, establishing it as the core active ingredient in the field of joint repair. This ingredient precisely targets joint cartilage through the Oral Immune Tolerance Mechanism, effectively inhibiting the release of pro-inflammatory cytokines to block cartilage degradation at its source, while gently stimulating chondrocyte regeneration to facilitate gradual repair of damaged and worn cartilage. It offers dual benefits of anti-inflammatory action and repair promotion, with efficacy far superior to traditional glucosamine and chondroitin formulas.

MAG Fast Joint Health 1+1 features an "AM/PM Dosing Formula" with precision ingredient formulation and layered efficacy profile. The AM tablet is formulated with glucosamine, LetopCs® low-molecular-weight chondroitin sulfate (≤1000 Daltons), and MSM (Methylsulfonylmethane), providing basic nutritional support for joints during the day to lubricate joint cavities and reduce wear from daily activities; the PM tablet contains 40mg of UC-II® Undenatured Type II Collagen, combined with green-lipped mussel, turmeric extract, and manganese, deeply inhibiting joint inflammation at night and promoting cartilage regeneration and repair. This creates a synergistic mechanism of "daytime defnese & nighttime repair", delivering 1+1>2 synergistic care efficacy.

Authoritative Experimental Validation The efficacy of MAG Fast Joint Health 1+1 was verified through Multi-Period Controlled Trials conducted by the Institute of Animal Husbandry and Veterinary Medicine, Shandong Academy of Agricultural Sciences. Eighteen adult dogs were selected and randomly assigned to three groups: AM Tablet Group, PM Tablet Group, and Combined AM/PM Group, with 4 small breed dogs and 2 large breed dogs in each group, ensuring broad applicability across different dog body types. Three experimental phases were implemented: 14-day short-term, 21-day medium-term, and 40-day long-term. The efficacy and safety of MAG Fast Joint Health 1+1 underwent comprehensive evaluation across four key dimensions: Feeding status, Joint Function, Blood Biomarkers, and Joint Imaging Assessments. The experimental data is objective and rigorous, with conclusions that are authoritative and scientifically validated.

Efficacy Validation Results Rapid Effects, Short-Term Improvement: Experimental data shows significant efficacy in the Combined AM/PM Group. On Day 5, hip pain scores in dogs and cats decreased by 17%, knee joint range of motion increased by 3%, and weight-bearing discomfort was initially relieved; on Day 7, lameness scores decreased by 25%, representing a 2.86 times greater improvement than the AM Tablet Group; on Day 14, lameness scores decreased by 41.5%, with significant improvement in joint mobility, providing initial confirmation of the product's short-term efficacy in relieving joint discomfort.

Deep Repair, Multi-Dimensional Improvement: In the 21-day mid-term trial, the Combined AM/PM Group demonstrated a 72.67% reduction in knee pain scores in dogs, with hip pain improvement 1.72 times greater than the Single Regimen Group; blood tests revealed that pro-inflammatory cytokine IL-6 (Interleukin-6) levels were 63.69% lower than the AM Tablet Group, and inflammatory marker CRP (C-Reactive Protein) decreased by 46.77%, exhibiting significant anti-inflammatory efficacy. The 40-day long-term trial further confirmed that the Combined Group achieved a 12.89% increase in knee joint range of motion, with lameness and weight-bearing scores reduced to 0, indicating complete restoration of joint function; total antioxidant capacity also increased by 41.38%, and bone resorption marker CTX-1 (C-Terminal Telopeptide of Type I Collagen) levels were significantly reduced, effectively inhibiting bone resorption and preserving cartilage structure.

Structural Repair, Visible Efficacy: 40-day joint MRI (Magnetic Resonance Imaging) scans revealed that dogs and cats in the Combined AM/PM Group exhibited intact joint architecture, regular bone morphology, and uniform joint space, with no evidence of bone sclerosis, abnormal calcification, or cartilage erosion, and stable cartilage density, visually demonstrating the product's role in repairing and protecting joint structures.

Safety Verification Results During the study duration, all dogs and cats across treatment groups exhibited normal food intake, water consumption, and behavioral status, with no significant fluctuations in body weight and no adverse reactions such as vomiting, diarrhea, or anorexia. Serum biochemistry analyses conducted at 21 days and 40 days showed that markers of hepatic and renal function, including Alanine Aminotransferase (ALT), Alkaline Phosphatase (ALP), Creatinine (Cr), and Blood Urea Nitrogen (BUN), remained within normal physiological ranges. Long-term administration demonstrated no hepatic or renal strain, fully confirming the product's safety profile.

Product Quality Assurance MAG Fast Joint Health 1+1 upholds stringent quality standards with a scientifically formulated blend. The PM Tablet features UC-II® Undenatured Type II Collagen, using patented imported raw materials from Lonza, USA, with patent certifications across 9 countries worldwide; the AM Tablet contains human-grade imported Glucosamine Hydrochloride and Low-Molecular-Weight Chondroitin Sulfate, meeting international standards for purity and bioactivity. The formula is free from palatability enhancers, preservatives, colorants, and artificial dyes, boasting higher ingredient purity than comparable human-grade supplements. The product has earned certifications from leading international authorities including IKOS, FDA, NSF, Eurofins, and SGS, ensuring consistent compliance and reliability. Packaged in pharmaceutical-grade aluminum foil blisters with individual tablet sealing, it provides oxygen-barrier protection for freshness preservation and precise dosage control, guaranteeing the bioactivity of each tablet while ensuring convenient, hygienic use.

Applicable Objects & Feeding Method This product is applicable for dogs and cats experiencing joint discomfort, degenerative joint conditions, or sports-related injuries, including senior, large-breed sporting and joint disease-prone breeds. It is also suitable for daily joint preventive care. Feeding is simple with weight-agnostic dosing: administer 1 tablet every morning and evening (AM Tablet + PM Tablet), either directly or mixed with food. Three boxes constitute one maintenance cycle. Long-term supplementation supports sustained joint health, restoring mobility and enabling an active, pain-free lifestyle for your pets.

Since entering the market in 2012, MAG has consistently upheld the core philosophy of "Let's Give It More". Focused on addressing the health needs of pets throughout their entire lifecycle, the brand is backed by cutting-edge research and built on stringent quality standards. MAG leverages global expertise through deep partnerships with leading international enterprises including Lonza (USA), Lallemand (France), Kaneka (Japan), Hilmar (USA), and Aker (Norway). By integrating world-class technologies and premium raw material resources, supported by a professional R&D team and rigorous quality control system, MAG crafts high-quality pet nutritional supplements that drive the evolution of the premium pet care industry.

Looking ahead, MAG will remain steadfast in its core commitment to scientific innovation and uncompromising quality. With pet health at the heart of everything we do, we will continue to push the boundaries of cutting-edge nutritional science, expand our product portfolio, and enhance product efficacy and bioavailability. Simultaneously, we champion evidence-based pet care principles and are dedicated to fostering a harmonious human-animal bond ecosystem. Our mission is to ensure every fur baby enjoys a healthy, vibrant life, fostering longer, more joyful companionships with their beloved owners.